Status:
RECRUITING
The Level of Patient Participation in Lung and Esophageal Cancer Patients Treated With Definitive Radiochemotherapy.
Lead Sponsor:
Sun Yat-sen University
Conditions:
Lung Cancer
Esophageal Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
This study aims to assess the level of participation of thoracic cancer patients undergoing definitive radiotherapy and chemotherapy ± immunotherapy in their medical processes and the association betw...
Eligibility Criteria
Inclusion
- Locally advanced non-small cell lung cancer, limited-stage small cell lung cancer, and esophageal cancer.
- Planned to undergo definitive chemoradiotherapy ± immunotherapy;
- Males or females aged 18 to 75;
- Able to communicate with medical staff.
Exclusion
- Patients with cognitive impairments.
Key Trial Info
Start Date :
June 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06019455
Start Date
June 1 2022
End Date
May 30 2027
Last Update
December 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen University
Guangzhou, China, 510060